Helix BioPharma Ratios and Metrics

Market cap in millions CAD. Fiscal year is August - July.

Millions CAD. Fiscal year is Aug - Jul.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2016 - 2020
Period Ending	Jan '26 Jan 22, 2026	Jul '25 Jul 31, 2025	Jul '24 Jul 31, 2024	Jul '23 Jul 31, 2023	Jul '22 Jul 31, 2022	Jul '21 Jul 31, 2021	2016 - 2020
Market Capitalization	160	79	56	42	33	117	Upgrade
Market Cap Growth	173.64%	40.75%	34.21%	28.68%	-72.14%	63.19%	Upgrade
Enterprise Value	159	79	56	41	34	115	Upgrade
Last Close Price	2.09	1.07	1.15	1.05	0.95	4.15	Upgrade
PB Ratio	9.94	5.09	-626.39	-49.71	102.32	-84.09	Upgrade
P/TBV Ratio	-	-	-	-	102.32	-	Upgrade
Debt / Equity Ratio	0.02	0.02	-	-	7.74	-2.59	Upgrade
Quick Ratio	0.18	0.06	0.72	0.46	1.03	1.01	Upgrade
Current Ratio	0.23	0.13	0.92	0.53	1.08	1.04	Upgrade
Return on Equity (ROE)	-66.34%	-67.18%	-	-	-	-1205.79%	Upgrade
Return on Assets (ROA)	-30.36%	-33.25%	-458.65%	-166.12%	-96.84%	-127.23%	Upgrade
Return on Invested Capital (ROIC)	-39.28%	-42.61%	-	-407.18%	-150.82%	-212.98%	Upgrade
Return on Capital Employed (ROCE)	-29.40%	-34.60%	10265.60%	748.60%	-1887.50%	-4780.60%	Upgrade
Earnings Yield	-3.06%	-6.56%	-16.43%	-14.97%	-20.11%	-6.86%	Upgrade
FCF Yield	-2.63%	-4.83%	-9.28%	-13.18%	-19.94%	-7.94%	Upgrade
Buyback Yield / Dilution	-35.46%	-25.29%	-15.11%	-29.26%	-8.41%	-7.97%	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.